Press Release

Myomo, Inc. Files Registration Statement for Proposed Follow-On Offering

CAMBRIDGE, Mass., November 13, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, announced the filing of a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed underwritten follow-on public offering of shares of its common stock and accompanying warrants to purchase…

Read More

Myomo, Inc. Issues November 2017 Shareholder Letter

CAMBRIDGE, Mass., November 7, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today issued a letter to shareholders to give an update on third quarter 2017 and ongoing MyoPro® commercial activities. Read more.

Read More

Myomo, Inc. Reports Third Quarter 2017 Results

CAMBRIDGE, Mass., November 6, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today reports its financial results for the three and nine months ended September 30, 2017. Read more.

Read More

Myomo Enters Canadian Market

Ottobock to Distribute MyoPro® to Orthotics and Prosthetics Practices Throughout Country CAMBRIDGE, Mass., November 03, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that its Application for a Canadian Medical Device License has been approved by Health Canada. With the license, Myomo and its…

Read More

Myomo, Inc. Launches Awareness Program for Veterans of the U.S. Armed Forces

MyoPro® for Veterans is Designed to Broaden MyoPro Accessibility to the Many Veterans Who May Benefit. CAMBRIDGE, Mass., October 17, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical device company, today announced the launch of MyoPro For Veterans, a strategic awareness program that broadens accessibility of MyoPro powered…

Read More

Myomo, Inc. to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York

CAMBRIDGE, Mass., September 5, 2017 – Myomo, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that its Chairman and Chief Executive Officer, Paul R. Gudonis, and its Chief Financial Officer, Ralph Goldwasser, will present at the 19th Annual Rodman & Renshaw Global Investment Conference at the Lotte New York Palace Hotel in New…

Read More

Myomo, Inc. Reports Second Quarter 2017 Results

CAMBRIDGE, Mass., August 14, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today reports its financial results for the three and six months ended June 30, 2017. Read more.

Read More

Myomo, Inc. to Report Second Quarter 2017 Results on August 14, 2017

Management to hold a conference call at 4:30 p.m. EDT CAMBRIDGE, Mass., August 10th, 2017 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will release its unaudited financial results for the quarter ended June 30, 2017 on Monday, August 14, 2017, after the…

Read More

Myomo, Inc. Obtains CE Mark Approval for MyoPro®

Myomo, Inc. Obtains CE Mark Approval for MyoPro® Enables Company to Start Providing Devices in Europe CAMBRIDGE, Mass., July 31, 2017 – Myomo, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it has obtained CE Mark approval for commercial sale of its next-generation MyoPro myoelectric arm orthosis…

Read More

Myomo Expands Management Team

Myomo Expands Management Team to Accelerate Commercialization of MyoPro® Powered Orthosis CAMBRIDGE, Mass., July 25, 2017 – Myomo®, Inc. (NSYE MKT: MYO), a commercial stage medical robotics company, today announced the expansion of its management team with three new full-time positions in medical affairs, sales and marketing. The expansion marks the company’s accelerated commercialization of…

Read More